The convergence of semiconductor technology and drug discovery holds great promise in the pursuit for new medications and therapies

Harvard researchers have realized a key milestone in the quest for stable, scalable quantum computing, an ultra-high-speed technology that will enable game-changing advances in a variety of fields.

New technology will enable improved development of obesity and diabetes treatments.

Harvard University joins Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center as the initial four academic institutions to participate in LAB eN².